TREATMENT OF PURULENT HIDRADENITIS Russian patent published in 2022 - IPC A61K39/395 A61P17/00 C07K16/24 

FIELD: medicine; dermatology.

SUBSTANCE: group of inventions relates to the field of medicine, namely to dermatology; it is intended for the treatment of purulent hidradenitis. A method for the treatment of purulent hidradenitis in a human subject who has foci associated with purulent hidradenitis includes a stage of the injection to a subject of a pharmaceutical composition containing a pharmaceutically acceptable carrier and a number of an antibody to IL-1α, effective for the treatment of a symptom of purulent hidradenitis in a subject. The use of a pharmaceutical composition, containing a pharmaceutically acceptable carrier and a number of an antibody to IL-1α for the treatment of purulent hidradenitis in a human subject who has foci associated with purulent hidradenitis, is also presented. In another embodiment, the use of an antibody to IL-1α is provided in the manufacture of a drug for the treatment of purulent hidradenitis in a human subject who has foci associated with purulent hidradenitis.

EFFECT: use of the group of inventions allows for an increase in the efficiency of reduction in the number and/or size of inflammatory foci of purulent hidradenitis.

42 cl, 12 dwg, 4 tbl, 2 ex